Ovid Therapeutics Gears Up for Investor Conferences in September
![Ovid Therapeutics Gears Up for Investor Conferences in September](https://investorshangout.com/images/blog/ihnews-Ovid%20Therapeutics%20Gears%20Up%20for%20Investor%20Conferences%20in%20September.jpg)
Ovid Therapeutics Excited about Upcoming Investor Conferences
Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to enhancing the lives of those affected by rare epilepsies and brain conditions, recently announced exciting news regarding its participation in two prominent investor conferences this September.
Details of the Upcoming Conferences
Management from Ovid will showcase their innovative approaches at the following events:
H.C. Wainwright 26th Annual Global Investment Conference
Ovid is set to present at the H.C. Wainwright conference on September 10th at 3:30 p.m. ET, where attendees can expect insights into the company's groundbreaking research and developments.
Cantor Global Healthcare Conference
Additionally, the company will engage in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 17th, at 1:55 p.m. ET. This interactive format will allow for meaningful exchanges regarding Ovid's mission and future strategies.
Webcast Access
For those interested in attending virtually, live webcasts of both the fireside chat and the presentation will be accessible through the Events & Presentations section of Ovid’s website. An archived replay will also be made available following the presentations, ensuring that stakeholders can stay informed.
About Ovid Therapeutics
Founded in New York, Ovid Therapeutics is committed to developing novel therapies for rare epilepsies and brain-related conditions. The company is advancing a promising pipeline of targeted small molecules that are designed to address the underlying factors contributing to neuronal hyperexcitability, which is known to cause seizures and various neurological symptoms.
Innovative Product Pipeline
Ovid is working on several key developments:
- OV888/GV101: A potent ROCK2 inhibitor aimed at treating cerebral cavernous malformations and other rare neurological diseases.
- OV329: A GABA-aminotransferase inhibitor, which shows potential in treating patients with treatment-resistant seizures.
- OV350: A direct activator of the KCC2 transporter being explored as a therapy for epilepsies and other psychiatric conditions.
For more details about these and other research initiatives, please visit Ovid Therapeutics' official website.
Stay Connected with Investor Relations
For further inquiries, investors can reach out to Garret Bonney at 617-735-6093 or via email at gbonney@ovidrx.com. Ovid Therapeutics values open communication with its investors and aims to keep them updated on its progress and strategic plans.
Frequently Asked Questions
What is the purpose of the upcoming investor conferences?
The conferences aim to share insights about Ovid's advancements in treatments for rare epilepsies and brain conditions.
When is Ovid presenting at the H.C. Wainwright conference?
Ovid will present on September 10th at 3:30 p.m. ET.
Where can I access the webcasts of the presentations?
The live webcasts will be available through the Events & Presentations section of Ovid's website, along with archived replays.
What are some products in Ovid's pipeline?
Ovid is developing OV888, OV329, and OV350, each targeting specific neurological conditions and challenges.
Who can I contact for more information about Ovid's investor relations?
Garret Bonney is the point of contact for investor relations; he can be reached at 617-735-6093 or via email at gbonney@ovidrx.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Mazda Achieves Remarkable Sales Growth in August Reports
- Experience Romance at Fairmont Orchid Inspired by 'The Bachelorette'
- Binswanger Welcomes Brooke Oldt as Senior VP of Corporate Services
- Senior Insurance Solutions Partners with Integrity for Growth
- GlobalVetLink's Automation Tool Enhances Rabies Vaccine Management
- CIBC Mellon, UPP & IMCO to Host Investment Fund Conference
- Ilegal Mezcal Launches Unique Reposado Caribbean Cask Finish
- Hackensack Meridian Health Foundation Gala Honors Eli Manning
- UK Investor Behavior: Shift from Stocks to Money Markets
- Apple's Anticipated 'Glowtime' Event to Unveil Innovations
- Dollar Tree's Earnings Drop and Future Outlook Challenges
- Rising Bankruptcy Filings in Commercial Sector Highlight Trends
- Prepare for Safety: Michigan Church Security Conference 2024
- HHRD Launches Fundraiser for Bangladesh Flood Relief Efforts
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Goya Foods Launches GOYA® Cares Hydrate for Hope Campaign
- Acer Introduces Eco-Friendly Vero PD2 Series LED Projectors
- Tower Arch Capital Partners with ACS Manufacturing for Growth
- Winking Studios Unveils GenMotion.AI for 3D Animation Innovation
- Bybit Web3 Launches Babylon Season with Exciting Opportunities
- Wells Fargo Advises Investors to Buy Election Weakness
- Super Micro Computer's Challenges After Recent Downgrade
- Blue Circle Health Launches New T1D Program in Northern States
- West Shore Home Appoints Al Patel as New Chief Marketing Officer
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
Recent Articles
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Bybit Web3 Launches Babylon Season with Exciting Opportunities
- Concerns Rise Over AI Firms Amid Short-Seller Activity
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
- TrustGrid Partners with Department of Air Force for Innovation
- Innovations Fueling Growth in the Sustainable Label Market
- Thumzup Media Engages Community at Upcoming Festivals
- Flexential's Innovative Growth Strategies Set for 2024 Success
- Solid Waste Management Market Expected to Hit $440 Billion by 2032
- Innovative FlashBang System Launch by Deep Sentinel for Businesses
- LPL Financial's Strategic Acquisition of The Investment Center
- LIXTE Secures U.S. Patent for Innovative Cancer Treatments
- Panasonic Launches Cutting-Edge OLED and Mini-LED TVs in US
- EPAM Systems to Acquire NEORIS: Expanding Global Reach
- Constructor's AI Shopping Assistant Triumphs in 2024 Awards
- Lenire Tinnitus Treatment Shows Real-World Effectiveness
- US Futures Decline Amid Economic Growth Concerns
- Safe Harbor Financial Revamps Leadership with Contract Extensions
- Generac Highlights Importance of Power Outage Preparedness
- U.S. Steel's Future at Stake Amid Nippon Steel Buyout Talks
- Riad Salameh's Detention Continues Amid Ongoing Investigation
- Hormel Foods Lowers Sales Forecast Amid Production Issues
- Bitcoin's One-Month Low Affects Crypto-Linked Stocks' Prices
- Alamos Gold Unveils Exciting Developments at PDA Project
- Nykredit Realkredit A/S Adjusts Coupon Rates from September 2024